One Way Holdings LLC Sells 78,347 Shares of STERIS plc $STE

One Way Holdings LLC decreased its holdings in STERIS plc (NYSE:STE) by 93.4% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 5,499 shares of the medical equipment provider’s stock after selling 78,347 shares during the quarter. One Way Holdings LLC’s holdings in STERIS were worth $1,155,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of STE. NewEdge Advisors LLC increased its stake in shares of STERIS by 0.7% in the second quarter. NewEdge Advisors LLC now owns 8,118 shares of the medical equipment provider’s stock valued at $1,710,000 after buying an additional 56 shares in the last quarter. Root Financial Partners LLC grew its holdings in STERIS by 30.7% during the 1st quarter. Root Financial Partners LLC now owns 247 shares of the medical equipment provider’s stock worth $55,000 after acquiring an additional 58 shares during the last quarter. Taylor Frigon Capital Management LLC raised its stake in shares of STERIS by 0.9% in the third quarter. Taylor Frigon Capital Management LLC now owns 6,505 shares of the medical equipment provider’s stock worth $1,366,000 after acquiring an additional 58 shares during the last quarter. Strengthening Families & Communities LLC lifted its position in shares of STERIS by 0.6% during the third quarter. Strengthening Families & Communities LLC now owns 10,884 shares of the medical equipment provider’s stock worth $2,286,000 after purchasing an additional 61 shares in the last quarter. Finally, Mather Group LLC. lifted its position in shares of STERIS by 14.4% during the third quarter. Mather Group LLC. now owns 565 shares of the medical equipment provider’s stock worth $119,000 after purchasing an additional 71 shares in the last quarter. Institutional investors and hedge funds own 94.69% of the company’s stock.

Analyst Ratings Changes

STE has been the subject of several research analyst reports. Wall Street Zen cut shares of STERIS from a “strong-buy” rating to a “buy” rating in a research report on Sunday, October 11th. Piper Sandler restated an “overweight” rating and set a $275.00 target price (up from $270.00) on shares of STERIS in a research report on Friday, August 7th. UBS Group cut their price target on STERIS from $275.00 to $270.00 and set a “buy” rating on the stock in a research note on Friday, August 7th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of STERIS in a report on Monday, August 24th. Three research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, STERIS currently has an average rating of “Moderate Buy” and an average target price of $271.33.

STERIS Stock Down 0.0%

Shares of STERIS stock opened at $227.07 on Monday. The company has a quick ratio of 1.35, a current ratio of 1.91 and a debt-to-equity ratio of 0.23. STERIS plc has a 12 month low of $195.14 and a 12 month high of $269.44. The business has a fifty day simple moving average of $219.81 and a 200 day simple moving average of $225.20. The stock has a market cap of $22.14 billion, a PE ratio of 27.76 and a beta of 0.86.

STERIS (NYSE:STE) last issued its earnings results on Wednesday, August 5th. The medical equipment provider reported $2.59 EPS for the quarter, beating the consensus estimate of $2.49 by $0.10. The firm had revenue of $1.49 billion during the quarter, compared to the consensus estimate of $1.49 billion. STERIS had a net margin of 13.34% and a return on equity of 14.34%. The business’s quarterly revenue was up 7.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.34 earnings per share. STERIS has set its FY 2027 guidance at 11.000-11.300 EPS. Research analysts predict that STERIS plc will post 11.17 EPS for the current year.

STERIS Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, December 17th. Stockholders of record on Tuesday, November 17th will be given a $0.69 dividend. The ex-dividend date of this dividend is Tuesday, November 17th. This represents a $2.76 annualized dividend and a dividend yield of 1.2%. STERIS’s dividend payout ratio is presently 33.74%.

Insiders Place Their Bets

In other STERIS news, Director Mohsen Sohi sold 4,058 shares of the stock in a transaction that occurred on Wednesday, August 12th. The shares were sold at an average price of $235.78, for a total transaction of $956,795.24. Following the transaction, the director owned 24,305 shares in the company, valued at $5,730,632.90. This represents a 14.31% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.12% of the stock is owned by insiders.

About STERIS

STERIS plc (NYSE: STE) provides products and services designed to support infection prevention, procedural care and the safe manufacture of healthcare and life sciences products. Its offerings include surgical equipment and operating-room solutions, sterilization and decontamination systems, endoscopy products, cleaning and disinfection technologies, and related consumable products.

The company also provides outsourced sterilization and laboratory services through its Applied Sterilization Technologies business.